Clostridium difficile in solid organ transplant recipients

American Journal of Transplantation

Volumn 9, Issue SUPPL. 4, 2009, Pages

  Dubberke, E R ^a   Riddle, D J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic associated diarrhea; Clostridium difficile; Nosocomial infection; Pseudomembranous colitis; Solid organ transplant

Indexed keywords

AMPICILLIN; BLEACHING AGENT; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COLESTIPOL; COLESTYRAMINE; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METRONIDAZOLE; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAXIMIN; TACROLIMUS; VANCOMYCIN;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; AGING; ANTIBIOTIC PROPHYLAXIS; ANTIMICROBIAL THERAPY; ASCITES; BACTERIAL SPORE; BACTERIAL STRAIN; BACTERIUM CULTURE; CELL ASSAY; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; CYTOTOXICITY TEST; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EXPOSURE; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEVER; GRAFT RECIPIENT; HOSPITALIZATION; HUMAN; HUMORAL IMMUNITY; HYGIENE; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; LEUKOCYTOSIS; NONHUMAN; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RECURRENT INFECTION; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; HUMANS; ORGAN TRANSPLANTATION; RISK FACTORS;

EID: 72949097887     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02891.x     Document Type: Review

References (36)

1. Aslam S, Musher DM. An update on diagnosis, treatment, and prevention of Clostridium difficile-associated disease. Gastroenterol Clin North Am 2006 35 : 315 335.
2. Nomura K, Fujimoto Y, Yamashita M et al. Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents. Scand J Gastroenterol 2009 44 : 74.
3. Loo VG, Poirier L, Miller MA et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005 353 : 2442 2449.
4. Riddle DJ, Dubberke ER. Clostridium difficile infection in solid organ transplant recipients. Curr Opin Organ Transplant 2008 13 : 592 600.
5. Dallal RM, Harbrecht BG, Boujoukas AJ et al. Fulminant Clostridium difficile: An underappreciated and increasing cause of death and complications. Ann Surg 2002 235 : 363 372.
6. Albright JB, Bonatti H, Mendez J et al. Early and late onset Clostridium difficile-associated colitis following liver transplantation. Transpl Int 2007 20 : 856 866.
7. Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect 1998 40 : 1 15.
8. Shim JK, Johnson S, Samore MH, Bliss DZ, Gerding DN. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 1998 351 : 633 636. (Pubitemid 28098446)
9. Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000 342 : 390 397.
10. Munoz P, Giannella M, Alcala L et al. Clostridium difficile-associated diarrhea in heart transplant recipients: Is hypogammaglobulinemia the answer? J Heart Lung Transplant 2007 26 : 907 914.
11. Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ. Clostridium difficile-associated disease in a setting of endemicity: Identification of novel risk factors. Clin Infect Dis 2007 45 : 1543 1549.
12. Dubberke ER, Gerding DN, Classen D et al. Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol 2008 29 (Suppl 1 S81 S92.
13. Wilkins TD, Lyerly DM. Clostridium difficile testing: After 20 years, still challenging. J Clin Microbiol 2003 41 : 531 534.
14. Mohan SS, McDermott BP, Parchuri S, Cunha BA. Lack of value of repeat stool testing for Clostridium difficile toxin. Am J Med 2006 119 : 356 e357 358.
15. Stamper PD, Alcabasa R, Aird D et al. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol 2009 47 : 373 378.
16. Sunenshine RH, McDonald LC. Clostridium difficile-associated disease: New challenges from an established pathogen. Cleve Clin J Med 2006 73 : 187 197.
17. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007 45 : 302 307.
18. Johnson S, Peterson LR, Gerding DN. Intravenous metronidazole and Clostridium difficile-associated diarrhea or colitis. J Infect Dis 1989 160 : 1087 1088.
19. Louie T, Gerson M, Grimard D et al. Results of a phase III trial comparing tolevamar, vancomycin and metronidazole in patients with Clostridium difficile-associated diarrhea (CDAD) In : 47th Annual ICAAC 2007 Chicago : Interscience Conference on Antimicrobial Agents and Chemotherapy.
20. Hecht DW, Galang MA, Sambol SP, Osmolski JR, Johnson S, Gerding DN. In vitro activities of 15 antimicrobial agents against 110 toxigenic Clostridium difficile clinical isolates collected from 1983 to 2004. Antimicrob Agents Chemother 2007 51 : 2716 2719.
21. Apisarnthanarak A, Razavi B, Mundy LM. Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: Case series and review of the literature. Clin Infect Dis 2002 35 : 690 696.
22. Byrn JC, Maun DC, Gingold DS, Baril DT, Ozao JJ, Divino CM. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch Surg 2008 143 : 150 154 discussion 155.
23. Juang P, Skledar SJ, Zgheib NK et al. Clinical outcomes of intravenous immune globulin in severe Clostridium difficile-associated diarrhea. Am J Infect Control 2007 35 : 131 137.
24. Barbut F, Richard A, Hamadi K, Chomette V, Burghoffer B, Petit JC. Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 2000 38 : 2386 2388. (Pubitemid 30414372)
25. Surawicz CM. Role of probiotics in antibiotic-associated diarrhea, Clostridium difficile-associated diarrhea, and recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 2008 42 (Suppl 2 S64 70.
26. Wilcox MH. Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea. J Antimicrob Chemother 2004 53 : 882 884.
27. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: Case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 2003 36 : 580 585.
28. Curry SR, Marsh JW, Shutt KA et al. High frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital. Clin Infect Dis 2009 48 : 425 429.
29. Johnson S, Schriever C, Galang M, Kelly CP, Gerding DN. Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clin Infect Dis 2007 44 : 846 848.
30. Valiquette L, Cossette B, Garant MP, Diab H, Pepin J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 2007 45 (Suppl 2 S112 121.
31. Davey P, Brown E, Fenelon L et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2005 : 4:CD003543.
32. Gerding DN, Muto CA, Owens RC Jr. Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 2008 46 (Suppl 1 S43 49.
33. Boyce JM, Ligi C, Kohan C, Dumigan D, Havill NL. Lack of association between the increased incidence of Clostridium difficile-associated disease and the increasing use of alcohol-based hand rubs. Infect Control Hosp Epidemiol 2006 27 : 479 483.
34. Rupp ME, Fitzgerald T, Puumala S et al. Prospective, controlled, cross-over trial of alcohol-based hand gel in critical care units. Infect Control Hosp Epidemiol 2008 29 : 8 15.
35. Vernaz N, Sax H, Pittet D, Bonnabry P, Schrenzel J, Harbarth S. Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. J Antimicrob Chemother 2008 62 : 601 607.
36. Muto CA, Blank MK, Marsh JW et al. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. Clin Infect Dis 2007 45 : 1266 1273.